Sacral Neuromodulation



Fig. 28.1
2% Chlorhexidine gluconate cloth (Sage Products, Cary, IL, USA) for wiping area in pre-op



Cefazolin pre-op if not serious PCN allergy, Vancomycin if allergy or specific concern for MRSA

Intra-op:

Alcohol wipe of skin, allow to dry, 3M™ (Minneapolis, MN, USA) DuraPrep™, 3M™ (Minneapolis, MN, USA) Ioban™ dressing, antibiotic irrigation

Post-op:

Five days of oral antibiotic

There are also steps to be taken with draping which may decrease infection rate. It is not necessary to tape the buttocks apart and observe the anus for motor responses, even if that is the way you have always done it. A 3M™ Ioban™ drape covering the buttocks and pre-sacral area is adequate for visualization and may improve sterility (Fig. 28.2).

A213469_2_En_28_Fig2_HTML.jpg


Fig. 28.2
After wiping the skin with alcohol, allowing to dry, then prepping with DuraPrep™ (3M, Minneapolis, MN, USA), an Ioban™ drape (3M, Minneapolis, MN, USA) is used to cover the skin in the operative field. Care is taken to make it smooth, and the intergluteal fold is pulled apart and then allowed to return to its natural position so that the drape will dip down and allow ready visualization of the bellows. A 3M™ (Minneapolis, MN, USA) Steri-Drape™ Cesarean-Section Sheet and Pouch with Ioban™ is an excellent alternative as it has the proper opening size and orientation and a large fluid dam to collect irrigation fluids

During implantable pulse generator (IPG ) placement, pocket size, depth, and hemostasis are all issues that can impact infection rate and other local complications. Make sure the device is at least 2 cm beneath the skin, and creation of the pocket should use cautery and minimize blunt dissection to avoid bleeding. The pocket should be parallel to the skin and just the right size for the device to prevent flipping or undue pressure on the incision. Consider marking the pocket site with patient cooperation in pre-op for an unusual body habitus or specific patient concern such as need to wear a utility belt for work.



Infection Management


If there is any question about wound infection when converting a first stage procedure to a full implant, it is prudent to have a low threshold for removing the lead and waiting for it to heal fully before proceeding with a full implant at a later date. If there is an obvious acute infection, or persistent or recurrent draining sinus weeks or months after implant, the entire implanted system should be removed. Usually the lead extracts very easily from the pocket due to surrounding inflammation, and a separate pre-sacral incision can be avoided. I have never seen a subsequent problem arising from the lead site using this strategy, though I suppose it could happen. I have been asked many times if both components must be removed, or if a salvage procedure may be tried such as with penile prosthesis. I do not know for sure, but it seems both of these strategies are likely to fail. It is not that hard to replace a lead, and the potential benefit of leaving it in place does not seem like it would outweigh the obvious risk. It is also my practice to excise any pseudo capsule to speed up formation of granulation tissue. I do not attempt to close the wound, but allow to heal by secondary intention, and to encourage the use of a wound vacuum system whenever feasible. I generally wait for a minimum of 3 months before considering reimplant when indicated.


Lack of or Declining Efficacy


The best possible surgical technique is unlikely to make a difference in efficacy if the procedure is performed on a poor candidate. My suggestion is to stick with FDA-approved indications, and make sure diaries are used to demonstrate sufficient objective benefit in the relevant symptom categories. The change in symptoms should be obvious and dramatic, and patients should never be pushed into a full implant. Even adhering to these suggestions, there may be a hierarchy in terms of which patients are likely to do best and require the least amount of reprogramming or revisions. It appears that the therapy is most robust for the fecal incontinence indication. I base this statement on the experience of colorectal surgeons in the USA, who are, as a group, the newest to the therapy and the least experienced, yet their success rate approaches 90% [3], and also on some examples of lead placements I have seen which were adequate for FI control but not for urinary complaints (Fig. 28.3). After FI, OAB wet is the most robust indication, while OAB dry and OAB with pelvic pain are successively harder indications requiring the most precision in lead placement. NOUR is in its own separate category due to the difficulty in identifying an ideal candidate. It seems the more “motor” the problem is, the easier it is to achieve success with less rigorous technique, and the more “sensory” the disorder, the more critical lead placement is, even perhaps to the point of needing alternate nerve targets (pudendal) and requiring electrodiagnosis (EMG) to place the lead next to the nerve. While still unproven, I think “optimal lead placement and response pattern” (Figs. 28.4 and 28.5) is necessary to achieve the best clinical result, especially in the more challenging conditions [4]. If precision is not used, it is more likely that the potential role for pudendal lead placement, bilateral stimulation, or an alternative therapy such as intravesical botulinum toxin will be falsely elevated.

A213469_2_En_28_Fig3_HTML.jpg


Fig. 28.3
This is a fluoro image taken of a lead placed in a patient for mixed urinary and fecal incontinence. The lead is in S4, enters very lateral to the medial foraminal edge, and has the wrong depth and orientation in the lateral view. Somehow, the FI symptoms were improved, but the UI symptoms were not. A subsequent revision to a more ideal lead position resulted in improvement of both conditions


A213469_2_En_28_Fig4_HTML.jpg


Fig. 28.4
Optimal lead placement. Lateral View: Parallels fusion plane, enters above hillock, curves down; Distal contacts appear closer than proximal. AP View: Starts next to medial edge of foramen, curves out; proximal contacts appear closer than distal


A213469_2_En_28_Fig5_HTML.gif


Fig. 28.5
Optimal responses to lead placement

Lead migration can also be an explanation for declining efficacy (Fig. 28.6a, b). I attempt to place a curve in the tunnel between the lead insertion site and the connection site when doing a staged procedure, in order to provide some “slack” which may prevent outward migration from pulling on the lead from pressure on the IPG or buttocks for normal movement. Inward migration is more of a problem overall, in part related to tine design, which resists only outward extraction. The most common scenarios for inward migration is in thin patients, where a “knuckle” occurs at the pre-sacral site (Fig. 28.7a–c). In addition to the presence of a knuckle being undesirable from a patient comfort standpoint, it can also lead to inward migration of the lead when the knuckle is pressed against a hard surface, such as a chair, before the lead has fully healed into place. Care must be taken to make a large enough incision to place a Sen inside the incision, and lift up on the Sen while tracking back towards the insertion site and deeply over to the IPG .

A213469_2_En_28_Fig6_HTML.jpg


Fig. 28.6
Example of anterior migration: (a) Post IPG ; (b) Anterior migration. This figure, from the literature, was used to describe the problem of anterior lead migration. Note how thin the patient is, which is the typical scenario where this complication is a concern. Also note to poor position of the lead, and the likely consequence of lead migration resulting in movement of contact 3 (the only likely electrode to be of clinical benefit) which could predictably result in decreased efficacy and inability to correct with reprogramming. (Reprinted with permission from Deng DY, Gulati M, Rutman M, Raz S, Rodriguez LV. Failure of Sacral Nerve Stimulation Due to Migration of Tined Lead. J Urol.​ 2006 Jun;175(6):2182–5)

Jun 30, 2017 | Posted by in UROLOGY | Comments Off on Sacral Neuromodulation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access